While most institutions showed a trend towards risk reduction (HR < 1.00), the result from DCMC (HR, 0.67; 95% CI, 0.47–0.95) was individually significant.
← all excerpts
Association Between the Use of DPP4 Inhibitors and Metformin and the Risk of Cancer in Patients with Type 2 Diabetes: A Multicenter Retrospective Cohort Study Using the OMOP CDM Database.
1
—
—